Palbociclib Dimer Impurity 2 - Request Quote
Palbociclib Dimer Impurity 2
| SZ CAT No: | SZ-P015178 |
| CAS No | NA |
| Mol.F. | C48H58N14O4 |
| Mol.Wt. | 895.1 |
| Inv. Status | Under Synthesis |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Palbociclib Dimer Impurity 2 is chemically 6,6'-(3-hydroxy-1-oxobutane-1,3-diyl)bis(8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one). Palbociclib Dimer Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Palbociclib Dimer Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Palbociclib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Palbociclib Dimer Impurity 2
Purchase Palbociclib Dimer Impurity 2
Palbociclib Dimer Impurity 2 suppliers
Palbociclib Dimer Impurity 2 manufacturers
Palbociclib Dimer Impurity 2 price
Order Palbociclib Dimer Impurity 2
Enquire Palbociclib Dimer Impurity 2
Palbociclib Dimer Impurity 2 cost
Palbociclib Dimer Impurity 2 Supplier
Palbociclib Dimer Impurity 2 Distributor
Palbociclib Dimer Impurity 2 for Method Validation
Palbociclib Reference Standard
Palbociclib Dimer Impurity 2 for ANDA Filing
Palbociclib Dimer Impurity 2 for Forced Degradation Studies
Palbociclib Dimer Impurity 2 Identification Standards
Palbociclib Dimer Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.